Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2017 (2017), Article ID 6509184, 11 pages
https://doi.org/10.1155/2017/6509184
Research Article

Interaction of Solid Lipid Nanoparticles and Specific Proteins of the Corona Studied by Surface Plasmon Resonance

1Laboratorio de Investigación y Desarrollo de Bioactivos (LIDeB), Departamento de Ciencias Biológicas, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, La Plata, Argentina
2Laboratorio de Nanobiomateriales, Centro de Investigación y Desarrollo de Fermentaciones Industriales (CINDEFI), UNLP-CONICET, CCT La Plata, Departamento de Química, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, Calle 47 y 115, La Plata, Argentina
3Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas (INIFTA), CONICET-UNLP, CC 16 Suc 4, La Plata, 1900 Buenos Aires, Argentina

Correspondence should be addressed to Cecilia Y. Chain; moc.liamg@niahc.limay

Received 30 March 2017; Revised 5 June 2017; Accepted 15 June 2017; Published 25 July 2017

Academic Editor: Kimberly Hamad-Schifferli

Copyright © 2017 Mauricio E. Di Ianni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Luque-Michel, E. Imbuluzqueta, V. Sebastián, and M. J. Blanco-Prieto, “Clinical advances of nanocarrier-based cancer therapy and diagnostics,” Expert Opinion on Drug Delivery, vol. 14, no. 1, pp. 75–92, 2017. View at Publisher · View at Google Scholar
  2. D. Carradori, J. Eyer, P. Saulnier, V. Préat, and A. des Rieux, “The therapeutic contribution of nanomedicine to treat neurodegenerative diseases via neural stem cell differentiation,” Biomaterials, vol. 123, pp. 77–91, 2017. View at Publisher · View at Google Scholar
  3. P. L. Lam, W. Y. Wong, Z. Bian, C. H. Chui, and R. Gambari, “Recent advances in green nanoparticulate systems for drug delivery: Efficient delivery and safety concern,” Nanomedicine, vol. 12, no. 4, pp. 357–385, 2017. View at Publisher · View at Google Scholar
  4. M. Moritz and M. Geszke-Moritz, “Recent developments - In the application of polymeric nanoparticles as drug carriers,” Advances in Clinical and Experimental Medicine, vol. 24, no. 5, pp. 749–758, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Vedda and I. Villa I, “Medical applications of nanomaterials,” in Nano-Optics: Principles Enabling Basic Research and Applications, B. Di Bartolo, J. Collins, and L. Silvestri, Eds., NATO Science for Peace and Security Series B: Physics and Biophysics, pp. 369–386, Springer, Dordrecht, Netherlands, 2017. View at Publisher · View at Google Scholar
  6. P. Foroozandeh and A. A. Aziz, “Merging Worlds of Nanomaterials and Biological Environment: Factors Governing Protein Corona Formation on Nanoparticles and Its Biological Consequences,” Nanoscale Research Letters, vol. 10, no. 1, article no. 221, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Caracciolo, O. C. Farokhzad, and M. Mahmoudi, “Biological Identity of Nanoparticles In Vivo: Clinical Implications of the Protein Corona,” Trends in Biotechnology, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Gao and Q. He, “The interaction of nanoparticles with plasma proteins and the consequent influence on nanoparticles behavior,” Expert Opinion on Drug Delivery, vol. 11, no. 3, pp. 409–420, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Gunawan, M. Lim, C. P. Marquis, and R. Amal, “Nanoparticle-protein corona complexes govern the biological fates and functions of nanoparticles,” Journal of Materials Chemistry B, vol. 2, no. 15, pp. 2060–2083, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Lazarovits, Y. Y. Chen, E. A. Sykes, and W. C. W. Chan, “Nanoparticle-blood interactions: the implications on solid tumour targeting,” Chemical Communications, vol. 51, no. 14, pp. 2756–2767, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Aggarwal, J. B. Hall, C. B. McLeland, M. A. Dobrovolskaia, and S. E. McNeil, “Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy,” Advanced Drug Delivery Reviews, vol. 61, no. 6, pp. 428–437, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. J. S. Suk, Q. Xu, N. Kim, J. Hanes, and L. M. Ensign, “PEGylation as a strategy for improving nanoparticle-based drug and gene delivery,” Advanced Drug Delivery Reviews, vol. 99, pp. 28–51, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. G. D. Mogoşanu, A. M. Grumezescu, C. Bejenaru, and L. E. Bejenaru, “Polymeric protective agents for nanoparticles in drug delivery and targeting,” International Journal of Pharmaceutics, vol. 510, no. 2, pp. 419–429, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Anselmo and S. Mitragotri, “Nanoparticles in the Clinic,” Bioengineering & Translational Medicine, vol. 1, no. 1, 2016. View at Google Scholar
  15. B. Rodenak-Kladniew, G. Islan, M. de Bravo, N. Durán, G. Castro, and G. R. Design, “Characterization and in vitro evaluation of linalool-loaded solid lipid nanoparticles as potent tool in cancer therapy,” Colloids and Surfaces B: Biointerfaces, vol. 154, 2017. View at Google Scholar
  16. W. Mehnert and K. Mäder, “Solid lipid nanoparticles: production, characterization and applications,” Advanced Drug Delivery Reviews, vol. 64, pp. 83–101, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Schwarz and W. Mehnert, “Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN),” International Journal of Pharmaceutics, vol. 157, no. 2, pp. 171–179, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Homola, “Surface Plasmon Resonance Based Sensors,” in Methods and Applications, O. S. Wolfbei, Ed., vol. 4 of Springer Series on Chemical Sensors and Biosensors, pp. 45–67, Springer-Verlag, Berlin, Heidelberg, Germany, 2006. View at Publisher · View at Google Scholar
  19. N. J. de Mol and M. J. Fischer, Surface Plasmon Resonance Methods and Protocols, Springer, London, 2010.
  20. X. Guo, “Surface plasmon resonance based biosensor technique: a review,” Journal of Biophotonics, vol. 5, no. 7, pp. 483–501, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. H. H. Nguyen, J. Park, S. Kang, and M. Kim, “Surface plasmon resonance: a versatile technique for biosensor applications,” Sensors (Switzerland), vol. 15, no. 5, pp. 10481–10510, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Canovi, J. Lucchetti, M. Stravalaci et al., “Applications of Surface Plasmon Resonance (SPR) for the characterization of nanoparticles developed for biomedical purposes,” Sensors (Switzerland), vol. 12, no. 12, pp. 16420–16432, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. O. K. Kari, T. Rojalin, S. Salmaso et al., “Multi-parametric surface plasmon resonance platform for studying liposome-serum interactions and protein corona formation,” Drug Delivery and Translational Research, vol. 7, no. 2, pp. 228–240, 2017. View at Publisher · View at Google Scholar
  24. B. J. Crielaard, A. Yousefi, J. P. Schillemans et al., “An in vitro assay based on surface plasmon resonance to predict the in vivo circulation kinetics of liposomes,” Journal of Controlled Release, vol. 156, no. 3, pp. 307–314, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Morelli, L. Plotkin, J. Leoni, C. A. Fossati, and R. A. Margni, “Analysis of oligosaccharides involved in the asymmetrical glycosylation of igg monoclonal antibodies,” Molecular Immunology, vol. 30, no. 7, pp. 695–700, 1993. View at Publisher · View at Google Scholar · View at Scopus
  26. V. Venkateswarlu and K. Manjunath, “Preparation, characterization and in-vitro release kinetics of clozapine solid lipid nanoparticles,” Journal of Controlled Release, vol. 95, no. 3, pp. 627–638, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Islan, P. Tornello, G. Abraham, N. Duran, and G. Castro, “Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization,” Colloids and Surfaces B: Biointerfaces, vol. 143, pp. 168–176, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. R. M. Shah, F. Malherbe, D. Eldridge, E. A. Palombo, and I. H. Harding, “Physicochemical characterization of solid lipid nanoparticles (SLNs) prepared by a novel microemulsion technique,” Journal of Colloid and Interface Science, vol. 428, pp. 286–294, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Pozzi, G. Caracciolo, L. Digiacomo et al., “The biomolecular corona of nanoparticles in circulating biological media,” Nanoscale, vol. 7, no. 33, pp. 13958–13966, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. G. T. Hermanson, Bioconjugate Techniques, Academic Press, San Diego, California, 2008.
  31. M. Halayqa and U. Domańska, “PLGA biodegradable nanoparticles containing perphenazine or chlorpromazine hydrochloride: effect of formulation and release,” International Journal of Molecular Sciences, vol. 15, no. 12, pp. 23909–23923, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. N. S. Berchane, K. H. Carson, A. C. Rice-Ficht, and M. J. Andrews, “Effect of mean diameter and polydispersity of PLG microspheres on drug release: Experiment and theory,” International Journal of Pharmaceutics, vol. 337, no. 1-2, pp. 118–126, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Caldorera-Moore, N. Guimard, L. Shi, and K. Roy, “Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers,” Expert Opinion on Drug Delivery, vol. 7, no. 4, pp. 479–495, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Zhang and M. Zhang, “Calcium phosphate/chitosan composite scaffolds for controlled in vitro antibiotic drug release,” Journal of Biomedical Materials Research, vol. 62, no. 3, pp. 378–386, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Decuzzi and M. Ferrari, “The role of specific and non-specific interactions in receptor-mediated endocytosis of nanoparticles,” Biomaterials, vol. 28, no. 18, pp. 2915–2922, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Ahmadi, Z. Oveisi, S. Mohammadi Samani, and Z. Amoozga, “Chitosan based hydrogels: characteristics and pharmaceutical applications,” Research in Pharmaceutical Sciences, vol. 10, 2015. View at Google Scholar
  37. G. Z. Kyzas and D. N. Bikiaris, “Recent modifications of chitosan for adsorption applications: A critical and systematic review,” Marine Drugs, vol. 13, no. 1, pp. 312–337, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Bekale, D. Agudelo, and H. A. Tajmir-Riahi, “Effect of polymer molecular weight on chitosan-protein interaction,” Colloids and Surfaces B: Biointerfaces, vol. 125, pp. 309–317, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. V. Boeris, B. Farruggia, and G. Picó, “Chitosan-bovine serum albumin complex formation: A model to design an enzyme isolation method by polyelectrolyte precipitation,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 878, no. 19, pp. 1543–1548, 2010. View at Publisher · View at Google Scholar · View at Scopus